BioUtah, the trade association and common voice for Utah’s life sciences community, today announced its participation in the J.P. Morgan 44th Annual Healthcare Conference, scheduled for January 11-16, 2026, in San Francisco. BioUtah President and CEO Kelvyn Cullimore will attend on behalf of the association, representing more than 1,600 life sciences companies across the state.
The conference serves as a premier gathering for the global healthcare industry, attracting investors, executives, and innovators. Utah’s life sciences sector, which includes strengths in medical device manufacturing, diagnostics, biotechnology, pharmaceuticals, and digital health, will be showcased during the event. BioUtah will co-host a state bio reception on Sunday night, January 11, 2026, providing an opportunity for networking and collaboration among attendees.
In addition to the conference, BioUtah encourages stakeholders to head to Salt Lake City March 12-13 for the 2026 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit and Snowbird ski day. Early bird registration is now open, offering a chance to engage with Utah’s vibrant life sciences ecosystem.
BioUtah’s participation underscores the importance of the J.P. Morgan Healthcare Conference as a platform for states like Utah to promote their life sciences industries. The association’s presence aims to attract investment, foster partnerships, and highlight Utah’s contributions to healthcare innovation. As a key driver of Utah’s economy, the life sciences sector continues to advance healthcare through cutting-edge research and development.
For more details, view the full announcement here. BioUtah is an independent 501(c)(6) trade association serving Utah’s life sciences industry, with member companies reflecting a broad spectrum of the industry, including medical device manufacturing, biotechnology, biopharmaceuticals, and diagnostics. The association is committed to advancing the life sciences community and its impact on global health.
